Search

everythinglearnresearchcommunity

for

Search:↓

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

BTA safely and effectively treats hair loss, and works better with FNS.

Botulinum toxin A has limited effectiveness for 3 months in treating female pattern hair loss and may reduce scalp oiliness.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Phosphatidylinositol 4-kinases are crucial for root growth, defense, and immunity in Arabidopsis thaliana.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

TGF-β is found in hair follicles and may cause hair loss in alopecia areata.

Fragile hair in children is rarely linked to trichothiodystrophy (TTD).

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

A rare autoimmune disease caused the woman's scalp blisters and hair loss, successfully treated with medication.

Human hair follicles have their own thyroid hormone system.

Biotin treatment improved hair and skin issues in a child with biotinidase deficiency.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

A new hair perming method avoids damage and lasts longer than traditional methods.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Combining NB-UVB 311 nm therapy with standard treatment improves hair regrowth in children with alopecia areata and atopic dermatitis.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Men seeking hair transplants show higher perfectionism and body dysmorphic disorder symptoms.

Baricitinib is effective and safe for treating severe alopecia areata.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.